how far away are we from implementing ctc-based approaches in prostate cancer?
Published 2 years ago • 54 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
4:12
active surveillance in localized prostate cancer
-
0:23
five facts about prostate cancer
-
15:27
how does prostate cancer chemotherapy work? | prolonged survival & improved cure rates | pcri
-
2:10
the harm-reduction approach to prostate cancer screening
-
10:36
state of the art - uncertainties in treatment of localised prostate cancer
-
11:36
gleason 9 & 10 prostate cancer: cure rates, treatments, new approaches | mark scholz, md | pcri
-
16:26
2023 recap: new treatments and approaches in #prostatecancer | #markscholzmd #alexscholx #pcri
-
18:56
making decisions after being diagnosed with early stage prostate cancer | uclamdchat
-
22:01
chemotherapy in #prostatecancer | the psa response & side effects | #markscholzmd #alexscholz
-
3:38
challenges of mri in prostate cancer
-
0:59
what is the most suitable treatment for prostate cancer? | tucker medical shorts
-
23:46
your gleason score matters | #prostatecancer #markscholzmd #alexscholz
-
51:25
11.23.2020 urology covid didactics - management of advanced prostate cancer
-
0:16
prostate cancer 🩻 #doctor #health #medical
-
27:03
segment 2: risk assessment in prostate cancer
-
47:46
spatial landscape of the immune microenvironment in metastatic prostate cancer...
-
3:01
about advanced (metastatic) prostate cancer
-
4:55
improving the psa test for screening prostate cancer
-
16:44
focal therapy for #prostatecancer: lowest risk of ed? | #markscholzmd #pcri #alexscholz